{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Clobazam  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clobazam. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clobazam  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "clobazam",
    "trial_2_text": "Clobazam  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Clobazam Supplement: 60 participants will take Clobazam 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clobazam. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clobazam  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "9": 0.28445833921432495,
      "17": 0.19854778051376343,
      "87": 0.1709989607334137,
      "173": 0.15936881303787231,
      "78": 0.131617933511734,
      "79": 0.11703663319349289,
      "228": 0.11312983185052872,
      "68": 0.11070777475833893,
      "49": 0.1099923625588417,
      "77": 0.10748431086540222,
      "46": 0.10690285265445709,
      "151": 0.1019737645983696,
      "177": 0.0966896116733551,
      "20": 0.09502338618040085,
      "64": 0.08662833273410797,
      "21": 0.08178547769784927,
      "76": 0.07905269414186478,
      "86": 0.0787230059504509,
      "123": 0.07591234892606735,
      "132": 0.07238472253084183,
      "37": 0.06529978662729263,
      "104": 0.0652935802936554,
      "29": 0.0642310082912445,
      "189": 0.0639728307723999,
      "30": 0.06371384114027023,
      "101": 0.06368250399827957,
      "466": 0.059448570013046265,
      "200": 0.0589943528175354,
      "239": 0.058862216770648956,
      "66": 0.058580003678798676,
      "102": 0.057475682348012924,
      "180": 0.05718426778912544,
      "188": 0.055348951369524,
      "14": 0.05395457148551941,
      "131": 0.05367198958992958,
      "114": 0.053020186722278595,
      "85": 0.05243757367134094,
      "28": 0.0502808578312397,
      "242": 0.0486343577504158,
      "116": 0.048440199345350266,
      "126": 0.047538384795188904,
      "67": 0.04738108441233635,
      "139": 0.0434572659432888,
      "61": 0.04321581497788429,
      "350": 0.04097385331988335,
      "96": 0.03851193189620972,
      "262": 0.03849470987915993,
      "11": 0.03682612627744675,
      "199": 0.03677978739142418,
      "396": 0.036691952496767044,
      "269": 0.0364307165145874,
      "92": 0.036370329558849335,
      "456": 0.03541501238942146,
      "5": 0.034951940178871155,
      "361": 0.03461366146802902,
      "36": 0.03445255756378174,
      "147": 0.03367547318339348,
      "345": 0.033558670431375504,
      "441": 0.033035263419151306,
      "38": 0.03260510414838791,
      "232": 0.03250390663743019,
      "15": 0.0317419171333313,
      "193": 0.03171316161751747,
      "18": 0.03088531643152237,
      "2": 0.030768465250730515,
      "98": 0.030122723430395126,
      "211": 0.029973581433296204,
      "27": 0.029722852632403374,
      "394": 0.02831953763961792,
      "243": 0.028300603851675987,
      "138": 0.02813609316945076,
      "276": 0.02812328189611435,
      "300": 0.028060680255293846,
      "221": 0.026678724214434624,
      "75": 0.026577739045023918,
      "72": 0.025444211438298225,
      "366": 0.02541450969874859,
      "69": 0.025304052978754044,
      "286": 0.025200532749295235,
      "203": 0.024469736963510513,
      "204": 0.02398594655096531,
      "31": 0.023702554404735565,
      "82": 0.023485256358981133,
      "179": 0.0234303567558527,
      "194": 0.022796664386987686,
      "234": 0.022791152819991112,
      "478": 0.022518761456012726,
      "253": 0.02207844890654087,
      "422": 0.02207024022936821,
      "355": 0.02183361165225506,
      "225": 0.021732524037361145,
      "261": 0.021634532138705254,
      "35": 0.021618736907839775,
      "282": 0.021455099806189537,
      "191": 0.02105426788330078,
      "152": 0.02097787894308567,
      "130": 0.02095538191497326,
      "249": 0.02064497210085392,
      "118": 0.020583415403962135,
      "410": 0.02017020806670189
    },
    "trial_2_ae": {
      "9": 0.28445833921432495,
      "17": 0.19854778051376343,
      "87": 0.1709989607334137,
      "173": 0.15936881303787231,
      "78": 0.131617933511734,
      "79": 0.11703663319349289,
      "228": 0.11312983185052872,
      "68": 0.11070777475833893,
      "49": 0.1099923625588417,
      "77": 0.10748431086540222,
      "46": 0.10690285265445709,
      "151": 0.1019737645983696,
      "177": 0.0966896116733551,
      "20": 0.09502338618040085,
      "64": 0.08662833273410797,
      "21": 0.08178547769784927,
      "76": 0.07905269414186478,
      "86": 0.0787230059504509,
      "123": 0.07591234892606735,
      "132": 0.07238472253084183,
      "37": 0.06529978662729263,
      "104": 0.0652935802936554,
      "29": 0.0642310082912445,
      "189": 0.0639728307723999,
      "30": 0.06371384114027023,
      "101": 0.06368250399827957,
      "466": 0.059448570013046265,
      "200": 0.0589943528175354,
      "239": 0.058862216770648956,
      "66": 0.058580003678798676,
      "102": 0.057475682348012924,
      "180": 0.05718426778912544,
      "188": 0.055348951369524,
      "14": 0.05395457148551941,
      "131": 0.05367198958992958,
      "114": 0.053020186722278595,
      "85": 0.05243757367134094,
      "28": 0.0502808578312397,
      "242": 0.0486343577504158,
      "116": 0.048440199345350266,
      "126": 0.047538384795188904,
      "67": 0.04738108441233635,
      "139": 0.0434572659432888,
      "61": 0.04321581497788429,
      "350": 0.04097385331988335,
      "96": 0.03851193189620972,
      "262": 0.03849470987915993,
      "11": 0.03682612627744675,
      "199": 0.03677978739142418,
      "396": 0.036691952496767044,
      "269": 0.0364307165145874,
      "92": 0.036370329558849335,
      "456": 0.03541501238942146,
      "5": 0.034951940178871155,
      "361": 0.03461366146802902,
      "36": 0.03445255756378174,
      "147": 0.03367547318339348,
      "345": 0.033558670431375504,
      "441": 0.033035263419151306,
      "38": 0.03260510414838791,
      "232": 0.03250390663743019,
      "15": 0.0317419171333313,
      "193": 0.03171316161751747,
      "18": 0.03088531643152237,
      "2": 0.030768465250730515,
      "98": 0.030122723430395126,
      "211": 0.029973581433296204,
      "27": 0.029722852632403374,
      "394": 0.02831953763961792,
      "243": 0.028300603851675987,
      "138": 0.02813609316945076,
      "276": 0.02812328189611435,
      "300": 0.028060680255293846,
      "221": 0.026678724214434624,
      "75": 0.026577739045023918,
      "72": 0.025444211438298225,
      "366": 0.02541450969874859,
      "69": 0.025304052978754044,
      "286": 0.025200532749295235,
      "203": 0.024469736963510513,
      "204": 0.02398594655096531,
      "31": 0.023702554404735565,
      "82": 0.023485256358981133,
      "179": 0.0234303567558527,
      "194": 0.022796664386987686,
      "234": 0.022791152819991112,
      "478": 0.022518761456012726,
      "253": 0.02207844890654087,
      "422": 0.02207024022936821,
      "355": 0.02183361165225506,
      "225": 0.021732524037361145,
      "261": 0.021634532138705254,
      "35": 0.021618736907839775,
      "282": 0.021455099806189537,
      "191": 0.02105426788330078,
      "152": 0.02097787894308567,
      "130": 0.02095538191497326,
      "249": 0.02064497210085392,
      "118": 0.020583415403962135,
      "410": 0.02017020806670189
    }
  },
  "safety": {
    "trial_1_safety": 0.35541754961013794,
    "trial_2_safety": 0.35541754961013794
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47719457745552063
  }
}